Inflammatory cytokines and chemokines (IL-6, IL-10, IL-17a, TNF-α, IP-10 and MCP-1) levels are significantly higher in the serum of ALS patients compared to controls. This evidence concerns the gene IL17A and amyotrophic lateral sclerosis.